Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening
Biomolecules · 04.07.2024 · 14 (7) · 794
DOI: 10.3390/biom14070794 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 04.07.2024. Verfasst von Haoyu Fang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Pathophysiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China. Hauptthemen laut MEDLINE: Organoids, Drug Evaluation, Preclinical, Liver. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Project of Jinan Microecological Biomedicine Shandong Laboratory, Fundamental Research Funds for the Central Universities, High-level personnel cultivating project of Zhejiang Province.
Abstract (Originalsprache)
Many drug and therapeutic modalities have emerged over the past few years. However, successful commercialization is dependent on their safety and efficacy evaluations. Several preclinical models are available for drug-screening and safety evaluations, including cellular- and molecular-level models, tissue and organoid models, and animal models. Organoids are three-dimensional cell cultures derived from primary tissues or stem cells that are structurally and functionally similar to the original organs and can self-renew, and they are used to establish various disease models. Human hepatobiliary organoids have been used to study the pathogenesis of diseases, such as hepatitis, liver fibrosis, hepatocellular carcinoma, primary sclerosing cholangitis and biliary tract cancer, as they retain the physiological and histological characteristics of the liver and bile ducts. Here, we review recent research progress in validating drug toxicity, drug screening and personalized therapy for hepatobiliary-related diseases using human hepatobiliary organoid models, discuss the challenges encountered in current research and evaluate the possible solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Pathophysiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
- Jinan Microecological Biomedicine Shandong Laboratory, Jinan 250117, China.
- State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center fo…
- Zhejiang Key Laboratory for Diagnosis and Treatment of Physic-Chemical and Aging-Related Injuries, 79 Qingchun Rd., Hangzhou 310003, China.
ORCID-Profile: Hongcui Cao
Förderung
- Research Project of Jinan Microecological Biomedicine Shandong Laboratory
- Fundamental Research Funds for the Central Universities
- High-level personnel cultivating project of Zhejiang Province
- Shandong Provincial Laboratory
Zitieren
APA
Fang, H., Xu, H., Yu, J., Cao, H., & Li, L. (2024). Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening. Biomolecules, 14(7), 794. https://doi.org/10.3390/biom14070794
Vancouver
Fang H, Xu H, Yu J, Cao H, Li L. Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening. Biomolecules. 2024;14(7):794. doi:10.3390/biom14070794
BibTeX
@article{Fang2024,
author = {Fang, Haoyu and Xu, Haoying and Yu, Jiong and Cao, Hongcui and Li, Lanjuan},
title = {Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {7},
pages = {794},
doi = {10.3390/biom14070794}
}
EUVIMED